AT349150B - METHOD FOR PRODUCING PHARMACEUTICAL POWDER - Google Patents

METHOD FOR PRODUCING PHARMACEUTICAL POWDER

Info

Publication number
AT349150B
AT349150B AT31875A AT31875A AT349150B AT 349150 B AT349150 B AT 349150B AT 31875 A AT31875 A AT 31875A AT 31875 A AT31875 A AT 31875A AT 349150 B AT349150 B AT 349150B
Authority
AT
Austria
Prior art keywords
pharmaceutical powder
producing pharmaceutical
producing
powder
pharmaceutical
Prior art date
Application number
AT31875A
Other languages
German (de)
Other versions
ATA31875A (en
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of ATA31875A publication Critical patent/ATA31875A/en
Application granted granted Critical
Publication of AT349150B publication Critical patent/AT349150B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
AT31875A 1974-01-18 1975-01-17 METHOD FOR PRODUCING PHARMACEUTICAL POWDER AT349150B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA00740385A ZA74385B (en) 1974-01-18 1974-01-18 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
ATA31875A ATA31875A (en) 1978-08-15
AT349150B true AT349150B (en) 1979-03-26

Family

ID=25567281

Family Applications (1)

Application Number Title Priority Date Filing Date
AT31875A AT349150B (en) 1974-01-18 1975-01-17 METHOD FOR PRODUCING PHARMACEUTICAL POWDER

Country Status (18)

Country Link
JP (1) JPS5837284B2 (en)
AT (1) AT349150B (en)
AU (1) AU485660B2 (en)
BE (1) BE824509A (en)
CA (1) CA1040532A (en)
CH (1) CH622947A5 (en)
DE (1) DE2501787A1 (en)
DK (1) DK151770C (en)
ES (1) ES433908A1 (en)
FI (1) FI750113A (en)
FR (1) FR2258177B1 (en)
GB (1) GB1478742A (en)
IE (1) IE40361B1 (en)
IT (1) IT1036072B (en)
LU (1) LU71668A1 (en)
NL (1) NL185130C (en)
SE (1) SE437930B (en)
ZA (1) ZA74385B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
PT75550B (en) * 1981-09-22 1984-12-12 Gist Brocades Nv Bismuth containing composition and method for the preparation thereof
US4801608A (en) * 1981-09-22 1989-01-31 Gist-Brocades N. V. Bismuth containing composition and method for the preparation thereof
JPS62502967A (en) * 1985-04-18 1987-11-26 ザ・プロクター・アンド・ギャンブル・カンパニー Treatment of non-ulcer dyspepsia
US4748113A (en) * 1985-06-13 1988-05-31 Marshall Barry J Compositions and methods for the diagnosis of gastrointestinal disorders involving urease
DE3686361T3 (en) * 1985-06-13 2003-01-09 Barry James Marshall Use of bismuth in the manufacture of medicaments for the treatment of gastrointestinal disorders caused by Campylobacter polyridis.
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
EP0462631B1 (en) * 1985-06-13 1996-03-20 Barry James Dr. Marshall Methods and compositions for the treatment of gastrointestinal disorders
DE3865201D1 (en) * 1988-10-08 1991-10-31 Pfleger R Chem Fab LIQUID, BISMUTH MEDICINE PREPARATION, METHOD FOR PRODUCING THE SAME AND THE USE THEREOF.
DE3901508C2 (en) * 1989-01-19 1994-04-07 Falk Pharma Gmbh Drug based on a bismuth-containing preparation in solid form
IT1229502B (en) * 1989-01-25 1991-09-03 Euroresearch Srl COMPOSITIONS CONTAINING BISMUTO SUITABLE FOR THERAPEUTIC USE.
IE893167A1 (en) * 1989-10-04 1991-04-24 Ulso Lab Ltd Preparation of orally administrable liquids for use in¹therapy
DK0540613T3 (en) * 1990-07-20 1996-04-01 Tillotts Pharma Ag Digestive tract products and methods
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
MX9703918A (en) 1997-05-28 1998-11-30 J Marshall M D Barry Procedure to prepare a reactive pharmaceutical product to detect gastrointestinal disorder caused by bacteria in superior gastrointestinal tract.
US7008777B2 (en) 2001-10-15 2006-03-07 Barry J. Marshall System for the detection of urease and method for using same
US6998250B2 (en) 2001-10-15 2006-02-14 Donald J. McMichael Method for detecting Helicobacter pylori
USD484988S1 (en) 2001-12-17 2004-01-06 Kimberly-Clark Worldwide, Inc. Diagnostic test kit with specimen-handling tool
US6783976B2 (en) 2001-12-21 2004-08-31 Kimberly-Clark Worldwide, Inc. Carrier and specimen-handling tool for use in diagnostic testing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1963781A1 (en) * 1968-12-23 1970-07-09 Serfontein Willem Jacob Improved bismuth preparations
DE1900268A1 (en) * 1968-12-23 1969-09-04 Serfontein Willem Jacob Bismuth complex preparation

Also Published As

Publication number Publication date
NL185130B (en) 1989-09-01
IE40361L (en) 1975-07-18
AU485660B2 (en) 1977-07-28
JPS5837284B2 (en) 1983-08-15
FR2258177B1 (en) 1978-07-21
DK151770C (en) 1989-11-06
SE7500501L (en) 1975-07-19
DE2501787C2 (en) 1987-11-12
ATA31875A (en) 1978-08-15
NL185130C (en) 1990-02-01
GB1478742A (en) 1977-07-06
BE824509A (en) 1975-07-17
SE437930B (en) 1985-03-25
ES433908A1 (en) 1976-11-16
NL7500552A (en) 1975-07-22
CA1040532A (en) 1978-10-17
IT1036072B (en) 1979-10-30
CH622947A5 (en) 1981-05-15
JPS50116623A (en) 1975-09-12
DE2501787A1 (en) 1975-07-24
DK12675A (en) 1975-09-15
IE40361B1 (en) 1979-05-09
FI750113A (en) 1975-07-19
AU7729375A (en) 1976-07-15
FR2258177A1 (en) 1975-08-18
DK151770B (en) 1988-01-04
LU71668A1 (en) 1975-06-24
ZA74385B (en) 1975-08-27

Similar Documents

Publication Publication Date Title
AT349150B (en) METHOD FOR PRODUCING PHARMACEUTICAL POWDER
AT352270B (en) METHOD FOR PRODUCING THE NEW CLAVULANIC ACIDS
DD129644A5 (en) PROCESS FOR PRODUCING NEW PROSTAGLAND INFOPED PRODUCTS
AT366576B (en) METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS
AT355897B (en) METHOD FOR PRODUCING CHOCOLATE PRODUCTS
AT345654B (en) FEED AND METHOD FOR PRODUCING THE SAME
AT344317B (en) METHOD FOR THE PRODUCTION OF MEDICINAL PRODUCTS
DD122963A5 (en) METHOD FOR PRODUCING FLUORIZED COMPOUNDS
AT342015B (en) METHOD FOR PRODUCING ACETOACETAMIDE-N-SULFOFLUORIDE
AT356648B (en) METHOD FOR PRODUCING NEW INDOLDER DERIVATIVES
AT344915B (en) METHOD FOR PRODUCING TABLETS
AT344136B (en) METHOD FOR PRODUCING NEW 2-DEUTERO-3-FLUOR-DL-ALANINE
DD132294A5 (en) METHOD FOR PRODUCING TOBACCO PRODUCTS
AT342191B (en) PROCESS FOR MANUFACTURING DRUG COMBINATIONS
AT361630B (en) METHOD FOR THE PRODUCTION OF MEDICINAL PRODUCTS
DD130933A5 (en) METHOD FOR PRODUCING SULFINYLAZETIDINONES
ATA924875A (en) PROCESS FOR PRODUCING NEW 5-NITROIMIDA ZOLDER DERIVATIVES
AT340546B (en) METHOD FOR PRODUCING ACID MASS
AT351523B (en) METHOD FOR PRODUCING 2-ALKYL-5-NITROIMIDAZOLE DERIVATIVES
AT342205B (en) METHOD FOR MANUFACTURING MEDICINAL BALLS
DD113583A2 (en) METHOD FOR PRODUCING SPATIAL CONSTRUCTION BODY
AT387375B (en) CONTINUOUS METHOD FOR PRODUCING CHLORDIOXIDE
AT374824B (en) METHOD FOR PRODUCING DETERGENT POWDERS
AT338974B (en) METHOD FOR PREPARING 7-AMINO-DELTA3-CEPHEM DERIVATIVES
ATA745075A (en) METHOD FOR PRODUCING ACETOACETAMIDE-N-SULFOFLUORIDE

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EIH Change in the person of patent owner
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee